Literature DB >> 7697970

Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature.

J M Durand1, P Lefevre, G Kaplanski, P Casanova, J Soubeyrand.   

Abstract

We describe two patients with the primary antiphospholipid syndrome who presented with severe hypertension. Renal biopsy specimen provided histologic evidence of intra-renal vascular disease with intravascular microthrombosis and nephrosclerosis, without feature of proliferative glomerulopathy. Accelerated hypertension and nephroangiosclerosis might indeed be one of the complications associated with anticardiolipin antibodies. The mechanism responsible might be the interaction of anticardiolipin antibodies, platelets and endothelial cell leading to microthrombi formation and increased local mitogenic activity that attract and stimulate neighbouring smooth muscle cell and fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697970     DOI: 10.1007/bf02243009

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome.

Authors:  S Inam; K Sidki; A R al-Marshedy; R Judzewitsch
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

2.  Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome.

Authors:  P A Ostuni; P Lazzarin; V Pengo; A Ruffatti; F Schiavon; P Gambari
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

3.  An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases.

Authors:  S B Ingram; S H Goodnight; R M Bennett
Journal:  Arthritis Rheum       Date:  1987-10

4.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.

Authors:  C G Mackworth-Young; S Loizou; M J Walport
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

Review 6.  Antiphospholipid antibody syndrome: immunologic and clinical aspects.

Authors:  L R Sammaritano; A E Gharavi; M D Lockshin
Journal:  Semin Arthritis Rheum       Date:  1990-10       Impact factor: 5.532

7.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.

Authors:  R J Friedman; M B Stemerman; B Wenz; S Moore; J Gauldie; M Gent; M L Tiell; H Spaet
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

10.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.